NEXT SCIENCE (NXSCF, $0.11) was a top loser over the last three months, falling to $0.11 per share. A.I.dvisor analyzed 244 stocks in the Pharmaceuticals: Other Industry for the 3-month period ending September 24, 2024, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.